Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Cytochrome P450 2B6 Inducers [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
CARBAMAZEPINE 24,577 2,156 8.8% 9,608 1,705 50.1 yrs 61.8%
NILOTINIB 23,171 4,543 19.6% 4,846 683 56.5 yrs 47.7%
RELUGOLIX 20,660 958 4.6% 1,699 37 72.4 yrs 1.4%
DABRAFENIB 19,305 4,165 21.6% 5,325 500 58.3 yrs 48.0%
CANNABIDIOL 18,243 1,563 8.6% 5,149 104 21.6 yrs 45.2%
PHENYTOIN 14,469 1,449 10.0% 5,241 1,087 46.5 yrs 50.7%
RITONAVIR 11,980 1,190 9.9% 2,925 350 43.8 yrs 43.8%
EFAVIRENZ 7,893 962 12.2% 1,528 252 40.7 yrs 37.7%
NEVIRAPINE 6,651 1,101 16.6% 979 152 35.8 yrs 45.5%
CENOBAMATE 5,643 125 2.2% 1,012 94 38.2 yrs 56.4%

Head-to-Head Comparisons

CARBAMAZEPINE vs NILOTINIB CARBAMAZEPINE vs RELUGOLIX CARBAMAZEPINE vs DABRAFENIB CARBAMAZEPINE vs CANNABIDIOL NILOTINIB vs RELUGOLIX NILOTINIB vs DABRAFENIB NILOTINIB vs CANNABIDIOL RELUGOLIX vs DABRAFENIB RELUGOLIX vs CANNABIDIOL DABRAFENIB vs CANNABIDIOL
← Back to Cytochrome P450 2B6 Inducers [MoA] Class side effects →